medigraphic.com
ISSN 0210-5187 (Electronic)

2009, Number 5

<< Back Next >>

Med Cutan Iber Lat Am 2009; 37 (5)

Generalized pustular psoriasis: treatment. with etanercept

Palomo AA, Torres ILM, Cervigón GI, Gil PB

Language: English
References: 16
Page: 224-226
PDF size: 282.88 Kb.


ABSTRACT

The treatment of acute generalized pustular psoriasis has classically been carried out with oral retinoids, cyclosporine, methotrexate, dapsone, colchicine, corticoids, coal tar or PUVA, slow and partial responses, as well as recurrences when the medication is decreased or suspended, being very relatively frequent. Several cases of acute generalized pustular psoriasis treated with infliximab and with quick and effective responses have recently been published based on the physiopathological relationship between the tumor necrosis factor (TNF) and psoriasis.


REFERENCES

  1. Von Zumbusch LR. Psoriasis und pustulöses Exanthem. Arch Dermatol Syph 1910; 99: 335-46.

  2. Zelickson BD, Muller SA. Generalized pustular psoriasis. A review of 63 cases. Arch Dermatol 1991; 127: 1339-45.

  3. García-Doval I, Peteiro C, Toribio J. Mortalidad en pacientes psoriásicos: a propósito de un caso de psoriasis pustulosa. Actas Dermosifiliogr 1995; 86: 363-5.

  4. Ikai K. Exacerbation and induction of psoriasis by angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 1995; 32: 819.

  5. Sterry W, Barker J, Boehncke WH et al. Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol 2004; 151: 3-17.

  6. Gamo R, López-Estebaranz JL. Terapia biológica y psoriasis. Actas Dermosifiliogr 2006; 97: 1-17.

  7. Gottlieb AB. Psoriasis: immunopathology and immunomodulation. Dermatol Clin 2001; 19: 649-57.

  8. Daudén Tello E, Oñate Cuchet MJ. Revisión monográfica de Enbrel (etanercept) para psoriasis y artritis psoriásica. Wyeth; 2005.

  9. López-Estebaranz JL. Etanercept. Estructura química, farmacocinética y mecanismo de acción. Actas Dermosifiliogr 2005; 96: 2-9.

  10. Eleweski B. Infliximab for the treatment of severe pustular psoriasis. J Am Acad Dermatol 2002; 47: 796-7.

  11. Newlan M, Weinstein A, Kerdel F. Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type. Int J Dermatol 2002; 41: 449-52.

  12. Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br J Dermatol 2004; 150: 1009-12.

  13. Trent JT, Kerdel FA. Successful treatment of von Zumbusch pustular psoriasis with infliximab. J Cutan Med Surg 2004; 8: 224-8.

  14. Lewis TG, Tuchinda C, Lim HW, Wong HK.Life-threatening pustular and erythrodermic psoriasis responding to infliximab. J Drugs Dermatol 2006; 5: 546-8.

  15. Kamarashev J, Lor P, Foster A, Heinzerling L, Burg G, Nestle FO. Generalized pustular psoriasis induced by cyclosporin A withdrawal responding to the tumor necrosis factor alpha inhibitor etanercept. Dermatology 2002; 205: 213-6.

  16. García-Patos Briones V. Seguridad de etanercept. Actas Dermosifiliogr 2005; 96: 25-32.




2020     |     www.medigraphic.com